Shobita Parthasarathy

Related News

Link to:Times of India publishes Q&A with newly-promoted Shobita Parthasarathy
Jul 03, 2018
The Times of India published a Q&A with Shobita Parthasarathy titled, " Indian-Americans need more role models in[...]
Link to:Shobita Parthasarathy’s book wins Robert K. Merton Book Award
Jun 13, 2018
Professor Shobita Parthasarathy’s book, Patent Politics: Life Forms, Markets, and the Public Interest in the United[...]
Link to:Michigan Radio features Parthasarathy on fostering grassroots innovation in Michigan
May 10, 2016
Shobita Parthasarathy’s research on grassroots innovation in India is featured on this week’s “The Next Idea,” a[...]
Link to:Parthasarathy discusses cracks in the patent system in The Conversation U.S.
Apr 06, 2016
On April 4th, The Conversation U.S. published Shobita Parthasarathy’s article entitled “CRISPR dispute raises bigger[...]
Link to:Parthasarathy receives IRWG funding to investigate gender, caste and innovation in India
Jan 20, 2016
Professor Shobita Parthasarathy has received a 2016 seed grant from Michigan's Institute for Research on Women and[...]


Related Past Events

Space is limited, but the event will be available via live webcast (see additional information below). No PowerPoint, no script; just stimulating conversation Nanotechnology has been touted variously as the next industrial revolution and the next asbestos. But where does the hype end and reality begin? And what does this mean for public health?
2011 - 2:00 pm to 3:00 pm
Should there be boundaries to patentable subject matter? What happens if the patents stifle innovation, rather than promoting it? How should we proceed if patents negatively influence health care, rather than enhancing it? The panel will discuss these questions by focusing on the controversy over patents on the breast and ovarian cancer (BRCA) genes, which led to a current ACLU class-action lawsuit against the U.S. Patent and Trademark Office and Myriad Genetics.
2009 - 4:00 pm to 5:30 pm